DOMS Industries (DOMS) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
8 Jul, 2026Executive summary
Q3 and nine-month FY26 saw strong year-over-year revenue and profit growth, driven by robust domestic demand, innovation-led product launches, and expanding export markets.
Capacity expansion included acquisition of land in Jammu, ongoing construction of a major facility in Gujarat, and brownfield/greenfield projects.
Product portfolio diversification and new launches were supported by R&D and the FILA partnership.
Strategic moves included a 50/50 JV with Seven SpA for premium backpacks and the incorporation of a CSR foundation.
Board approved ESOP allotments, increasing paid-up capital.
Financial highlights
Q3 FY26 consolidated revenue: ₹59,219.42 lakhs (₹592.2 crore), up 18.2% year-over-year; 9M FY26 revenue: ₹172,238.20 lakhs (₹1,722.4 crore), up 22.7%.
Q3 consolidated EBITDA: ₹10,340 lakhs (₹103.4 crore), margin at 17.5%; Q3 PAT: ₹6,123.29 lakhs (₹61.4 crore), margin at 10.4%.
9M FY26 EBITDA: ₹30,170 lakhs (₹301.7 crore), margin at 17.5%; 9M PAT: ₹17,909.55 lakhs (₹181.4 crore), margin at 10.5%.
Gross profit margin for Q3 FY26 at 44.2%, slightly higher year-over-year.
CapEx for FY26 expected to exceed ₹25,000 lakhs (₹250 crore); significant investments in property, plant, and equipment.
Outlook and guidance
FY26 revenue growth expected at the upper end of 18%-20% guidance, with similar momentum targeted for FY27.
Commercial operations at the new 44-acre Umbergaon facility expected to commence in Q2 FY27.
FY27 CapEx planned at ₹22,500-25,000 lakhs (₹225-250 crore), with phased capacity additions.
Joint venture with Seven SpA to be completed by June 30, 2026, targeting new product lines and global supply.
Focus on expanding product portfolio and leveraging recent acquisitions.
Latest events from DOMS Industries
- FY25 revenue up 24.4%, with 18%-20% growth and 16.5%-17.5% EBITDA margin guided for FY26.DOMS
Q4 24/259 Jul 2026 - Q2 FY26 saw strong revenue and profit growth, capacity expansion, and product diversification.DOMS
Q2 25/2619 Jun 2026 - Q3 FY25 revenue and profit surged, supported by acquisitions, capacity expansion, and IPO funds.DOMS
Q3 24/2519 Jun 2026 - FY26 revenue up 21.6% YoY, EBITDA margin 17.3%, PAT up 12.2%, strong domestic demand.DOMS
Q4 25/2619 May 2026 - Q1 FY25 saw strong revenue and profit growth, margin expansion, and strategic diversification.DOMS
Q1 24/252 Feb 2026 - Q2 FY25 revenue and profit rose sharply, aided by Uniclan acquisition and margin expansion.DOMS
Q2 24/2515 Jan 2026 - Q1 FY26 revenue rose 26.4% with strong margins, capacity expansion, and new product launches.DOMS
Q1 25/2623 Nov 2025